Virtual meeting
Via Zoom
Description
As part of the twice-monthly MA OBAT ECHO® series, Tae Woo (Ted) Park, MD, will review benzodiazepines, including their pharmacology and associated risks, particularly when combined with other substances, as well as how to identify, assess, and manage benzodiazepine use and withdrawal in patients with substance use disorder. The didactic will be followed by a de-identified patient case presentation from an ECHO® participant and recommendations from the panel of experts and attendees.
Boston Medical Center's (BMC) 12-part Massachusetts Office Based Addiction Treatment ECHO® (MA OBAT ECHO®) offers training and support in addiction treatment, with a focus on comprehensive care for patients with substance use disorders (SUDs). The free, case-based tele-mentoring program is designed to increase the capacity of primary care teams to integrate addiction treatment using a multidisciplinary care model.
Intended audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
Speakers
Tae Woo (Ted) Park, MD
Objectives
At the conclusion of this activity, participants will have the knowledge to:
- Discuss benzodiazepine pharmacology and associated risks, particularly when combined with other substances.
- Develop skills to identify, assess and manage benzodiazepine use and withdrawal in patients with substance use disorders.
Sponsored by
Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS).
Accreditation information
Please read the Accreditation Information section of the training page to learn about the requirements for receiving credit or a certificate of completion.
Audience
Providers, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians.
